Daily Journal Staff Writer
Paul Hastings LLP and Sidley Austin LLP represented La Jolla-based early-stage venture capital firm Avalon Ventures and U.K. pharmaceutical giant GlaxoSmithKline PLC, or GSK, respectively, in a $495 million collaboration between the companies, a deal announced Monday.
Lawyers involved heralded the deal - one of the largest of its kind - as indicative of an increasingly accepting attitude by large p...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In